Allarity Historical Income Statement
| ALLR Stock | USD 1.27 0.01 0.79% |
Historical analysis of Allarity Therapeutics income statement accounts such as Interest Income of 36.2 K, Depreciation And Amortization of 35.1 K or Selling General Administrative of 8.9 M can show how well Allarity Therapeutics performed in making a profits. Evaluating Allarity Therapeutics income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Allarity Therapeutics's future profits or losses.
Financial Statement Analysis is much more than just reviewing and examining Allarity Therapeutics latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Allarity Therapeutics is a good buy for the upcoming year.
Allarity |
About Allarity Income Statement Analysis
Allarity Therapeutics Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Allarity Therapeutics shareholders. The income statement also shows Allarity investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).
Allarity Therapeutics Income Statement Chart
Add Fundamental
Tax Provision
The amount set aside by a company to cover any estimated taxes for the current period. It reflects the company's expected tax liabilities.Net Interest Income
The difference between the revenue generated from a bank's interest-bearing assets and the expenses associated with paying its interest-bearing liabilities.Depreciation And Amortization
The systematic reduction in the recorded value of an intangible asset. This includes the allocation of the cost of tangible assets to periods in which the assets are used, representing the expense related to the wear and tear, deterioration, or obsolescence of physical assets and intangible assets over their useful lives.Total Revenue
Total revenue comprises all receipts Allarity Therapeutics generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.Other Operating Expenses
Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Allarity Therapeutics. It is also known as Allarity Therapeutics overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.Most accounts from Allarity Therapeutics' income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Allarity Therapeutics current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Allarity Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis. To learn how to invest in Allarity Stock, please use our How to Invest in Allarity Therapeutics guide.At this time, Allarity Therapeutics' Interest Expense is relatively stable compared to the past year. As of 11/25/2024, Interest Income is likely to grow to about 36.2 K, while Net Loss is likely to drop (25.4 M).
| 2021 | 2022 | 2023 | 2024 (projected) | Reconciled Depreciation | 106K | 60K | 30K | 46.9K | Total Operating Expenses | 26.6M | 16.9M | 17.9M | 17.8M |
Allarity Therapeutics income statement Correlations
Click cells to compare fundamentals
Allarity Therapeutics Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Allarity Therapeutics income statement Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Interest Expense | 3.3M | 227K | 499K | 223K | 498K | 543.9K | |
| Ebit | (17.6M) | (6.1M) | (26.0M) | (17.4M) | (12.1M) | (12.7M) | |
| Net Income Applicable To Common Shares | (132.0M) | (47.6M) | (26.6M) | (21.1M) | (24.2M) | (25.4M) | |
| Income Tax Expense | (4.6M) | (2.2M) | 133K | (1.5M) | (717K) | (752.9K) |
Pair Trading with Allarity Therapeutics
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Allarity Therapeutics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Allarity Therapeutics will appreciate offsetting losses from the drop in the long position's value.Moving together with Allarity Stock
Moving against Allarity Stock
The ability to find closely correlated positions to Allarity Therapeutics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Allarity Therapeutics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Allarity Therapeutics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Allarity Therapeutics to buy it.
The correlation of Allarity Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Allarity Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Allarity Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Allarity Therapeutics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for Allarity Stock Analysis
When running Allarity Therapeutics' price analysis, check to measure Allarity Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Allarity Therapeutics is operating at the current time. Most of Allarity Therapeutics' value examination focuses on studying past and present price action to predict the probability of Allarity Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Allarity Therapeutics' price. Additionally, you may evaluate how the addition of Allarity Therapeutics to your portfolios can decrease your overall portfolio volatility.